Founders
Prof. A. CAVALLI – University of Bologna & IIT Genova, Italy
Prof. G. COSTANTINO – University of Parma, Parma, Italy
Prof. G. CRUCIANI – University of Perugia, Perugia, Italy
Board of Directors (2022-2026)
Prof. Giovanni BOTTEGONI
University of Urbino, Urbino, Italy
Prof. Andrea CAVALLI
EPFL, Lausanne, Switzerland and University of Bologna, Bologna, Italy
Prof. Rebecca WADE (Scientific Chair)
Heidelberg University and HITS, Heidelberg, Germany
Early Career Board (2024-2026)
David SOTILLO NUNEZ
University of Urbino, Urbino, Italy
Dr. Karolina KOPANSKA
Pompeu Fabra University, Barcelona, Spain
Dr. Giulia Paiardi
NEC Oncoimmunity AS, Mannheim, Germany
International Scientific Advisory Committee
Prof. Rommie AMARO
University of California San Diego, San Diego, USA
Dr Albert A. ANTOLIN
VHIO, Barcelona, Spain
Dr Karl-Heinz BARINGHAUS
Sanofi, Frankfurt, Germany
Dr Andrea BECCARI
Dompé Pharma, L’Aquila, Italy
Prof. Andreas BENDER
Khalifa University, Abu Dhabi, United Arab Emirates
Dr Zoe COURNIA
Biomedical Research Foundation Academy of Athens, Athens, Greece
Prof Mark CRONIN
Liverpool John Moores University, Liverpool, United Kingdom
Prof. Matteo DAL PERARO (Chair of 26th EuroQSAR)
Ecole polytechnique fédérale de Lausanne, Lausanne, Switzerland
Dr Chris DE GRAAF
Structure Therapeutics, San Francisco, USA
Prof. Gerhard ECKER
University of Vienna, Vienna, Austria
Dr Peter ERTL
Ertl Molecular, Muenchenstein, Switzerland
Dr Catrin HASSELGREN
Genentech, South San Francisco, CA, United States
Dr Gerhard HESSLER
Sanofi, Frankfurt am Main, Germany
Prof. Alexander HILLISCH
UCB, Monheim am Rhein, Germany
Dr Edgar JACOBY
Janssen, Beerse, Belgium
Prof. William L. JORGENSEN
Yale University, New Haven, United States
Prof. Thierry LANGER
University of Vienna, Vienna, Austria
Prof. Andrew R. LEACH
LifeArc, London, United Kingdom
Prof. F. Javier LUQUE
University of Barcelona, Santa Coloma de Gramenet, Spain
Prof. Antonio MACCHIARULO
University of Perugia, Perugia, Italy
Dr Jonathan MASON
Design for Drug Discovery Consulting, United Kingdom
Prof. Jordi MESTRES (Chair of 24th EuroQSAR)
University of Girona, Girona, Spain
Prof. Adrian J MULHOLLAND
University of Bristol, Bristol, United Kingdom
Prof. Masha NIV
The Hebrew University, Rehovot, Israel
Prof. Tudor I. OPREA (Chair of 27th EuroQSAR)
Expert Systems Inc., San Diego, United States
Prof. Modesto OROZCO
University of Barcelona and IRB Barcelona, Spain
Dr. John OVERINGTON
Drughunter Inc., Portland, United States
Prof. Giulia PALERMO
University of California Riverside, Riverside, USA
Dr Margot PAULINO
FACULTAD DE QUIMICA, MONTEVIDEO, Uruguay
Prof. Antti POSO (Chair of 28th EuroQSAR)
University of Eastern Finland, Kuopio, Finland
Prof. Matthias RAREY
University of Hamburg, Hamburg, Germany
Prof. Sereina RINIKER
ETH, Zurich, Switzerland
Prof. Outi SALO-AHEN
Åbo Akademi University, Turku, Finland
Prof. Philippe SCHWALLER
EPFL, Lausanne, Switzerland
Dr Simone SCIABOLA
Biogen, Cambridge, MA, United States
Prof. Francesca SPYRAKIS
University of Turin, Turin, Italy
Prof. Wolfgang SIPPL
Martin-Luther-Universität Halle-Wittenberg, Halle, Germany
Dr Woody SHERMAN
Psivant Therapeutics, Boston, MA, USA
Dr Martin STAHL
Zenith Therapeutics, Basel, Switzerland
Prof. Alexander TROPSHA (Chair of 27th EuroQSAR)
University of North Carolina, Chapel Hill, United States
Prof. Anna TSANTILI-KAKOULIDOU
University of Athens, Athens, Greece
Prof. Alexandre VARNEK
University of Strasbourg, Strasbourg, France
Prof. Andrea VOLKAMER
Saarland University, Saarbruecken, Germany
Prof. Harel WEINSTEIN
Cornell University, New York, United States
Prof. David WINKLER
Monash University, Clayton, Australia
Dr Barbara ZDRAZIL
EMBL-EBI, Hinxton, United Kingdom